Neuland Laboratories Board Meeting on Aug 5 to Approve Q1 FY27 Results

Neuland Laboratories Ltd has announced that its Board of Directors will convene on August 5, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results, both standalone and consolidated, for the first quarter ended June 30, 2026. Additionally, the company confirmed that the trading window for its equity shares will remain closed from July 1, 2026, until 48 hours after the declaration of these financial results, in accordance with the company's Insider Trading Code.